Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of LUM mRNA | increases expression | 19933214
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of LUM protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of LUM mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of LUM mRNA | increases expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of LUM mRNA | decreases expression | 20713471
|
C095105 |
bexarotene |
bexarotene results in decreased expression of LUM mRNA | decreases expression | 16648578
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of LUM mRNA | decreases expression | 20739668
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of LUM mRNA | affects expression | 17484886
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of LUM mRNA | decreases expression | 20106945
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of LUM mRNA | decreases expression | 18042831
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of LUM mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of LUM mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LUM mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of LUM mRNA | decreases expression | 15834898 17557909
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased expression of LUM mRNA | increases expression | 15954086
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in decreased expression of LUM mRNA | decreases expression | 20713471
|
D015735 |
Mifepristone |
Mifepristone results in increased expression of LUM mRNA | increases expression | 17584828
|
C041786 |
palm oil |
palm oil results in decreased expression of LUM mRNA | decreases expression | 18042831
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of LUM mRNA] | affects reaction|decreases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in decreased expression of LUM mRNA | decreases expression | 19482888
|
C035988 |
procymidone |
procymidone results in decreased expression of LUM mRNA | decreases expression | 15686871
|
D020849 |
Raloxifene |
Raloxifene affects the expression of LUM mRNA | affects expression | 14699072
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of LUM mRNA | decreases expression | 18812580
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of LUM mRNA | affects expression | 17555576
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of LUM mRNA | affects expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of LUM mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of LUM mRNA | increases expression | 20067830
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LUM mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of LUM mRNA | increases expression | 19933214
|
D014302 |
Trinitrobenzenesulfonic Acid |
Trinitrobenzenesulfonic Acid results in increased expression of LUM mRNA | increases expression | 17982090
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of LUM mRNA | increases expression | 19101580
|
C025643 |
vinclozolin |
vinclozolin results in decreased expression of LUM mRNA | decreases expression | 15686871
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.38 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
13.20 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
13.20 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
13.20 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.77 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.39 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.77 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.03 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.03 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
10.78 | 6695378 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
10.78 | 6695378 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
10.78 | 10545420 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
9.51 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.51 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.53 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.73 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.43 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.50 | 15800139 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.06 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.80 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
8.40 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
8.40 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.90 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
9.34 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
9.34 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.56 | 15885639 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.35 | 11922910 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.02 | 18316065 18396377 15238991 18177632 20603192 17688650 18558336 17157402 18985861 17507914 18940202 19232924 19460635 18775368 16609825 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.99 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.89 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.62 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.66 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.66 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.71 | 11985600 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.73 | 14991843 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.30 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.14 | 16651633 15144691 18412241 16357521 16436596 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.60 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
4.60 | 16344269 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
4.60 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
4.60 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
4.60 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
4.60 | 16912660 15775269 16837676 17049068 15572757 15758505 17595753 17440819 17893378 17952589 17242785 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.60 | 17261762 17893378 19200415 15565566 19142967 20544844 19487384 19221464 21152245 15668708 19103187 18629630 18997820 19155303 19289846 20135344 20065188 18815881 19410462 11161223 18425577 19189210 16873071 19115204 16818667 19189212 18984771 18351453 18855134 19084267 20390343 19011961 20859285 19288272 18821012 17242785 19059307 17440819 21138602 20005174 16202921 19066611 19244106 16273361 17049068 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.60 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.61 | 3786805 15721981 16192424 15673190 16097048 16227642 18705752 15700767 16124888 16011737 16050911 10355542 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
7.88 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.88 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.34 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
8.57 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
8.57 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
8.57 | 1701930 6705139 20007298 17173139 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.57 | 17306315 16507464 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
8.57 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.82 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
3.17 | 16247446 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.43 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.43 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.00 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.00 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.27 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.33 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
15.13 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
15.13 | 16003739 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
15.13 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
15.13 | 19524636 20056578 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.08 | 4080065 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.81 | 17160924 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.65 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.36 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.36 | 16105132 15861022 17681005 17110522 16919318 17333356 11677210 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.03 | 8697196 16354765 15340226 12621046 15668235 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.45 | 15800139 |
MESH:D003092 |
Colitis |
|
Trinitrobenzenesulfonic Acid |
4.38 | 11698051 17991707 18200517 16867261 16804969 17936198 16782535 18023891 16474422 |
MESH:D003093 |
Colitis, Ulcerative |
|
Trinitrobenzenesulfonic Acid |
3.39 | 17276891 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.42 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.42 | 8888407 16575769 17688650 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.17 | 14966744 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.19 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.02 | 17474826 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.63 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
8.55 | 17451421 15920148 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.55 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
5.90 | 19336974 7440962 3732212 17522070 3786805 6623471 6884620 9327722 7179309 16227642 10092053 10915739 15998439 16177239 2869522 4309450 7120509 19085960 15027814 15968718 11566570 21278145 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.90 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
5.90 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.63 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.33 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
9.90 | 1851702 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
9.90 | 1851702 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.81 | 18357618 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.34 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.34 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.73 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
14.39 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
14.39 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
14.39 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
2.93 | 20544844 16202921 17893378 19155303 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
8.65 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.65 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
10.23 | 3659116 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
10.23 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
9.40 | 3922381 11558140 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
9.40 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
6.38 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
6.38 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
8.38 | 6401628 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
8.38 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
10.73 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
10.73 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
9.90 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
9.90 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.97 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.89 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
34.59 | 12795759 19224547 15959796 16045604 17595544 12631006 61145 16239168 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
34.59 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
34.59 | 18296743 17967931 19004024 19551842 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
34.59 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
34.59 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
34.59 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
34.59 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.13 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.29 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.71 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.96 | 8888407 18558336 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.35 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.01 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.77 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
25.93 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
25.93 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
25.93 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
25.93 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Trinitrobenzenesulfonic Acid |
25.93 | 17994277 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.76 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.13 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.51 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.05 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
3.72 | 16436596 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.43 | 16357521 16651633 18412241 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.42 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.15 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.15 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.42 | 11110106 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.25 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.18 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.43 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
7.88 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.88 | 16120746 15340226 12621046 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.57 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.01 | 12676792 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.69 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.87 | 8697196 16959395 15340226 18606429 16354765 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.36 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.44 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.45 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.20 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.20 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.20 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.92 | 15338365 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.64 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.30 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
10.55 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
10.55 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
10.55 | 16467254 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
7.76 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
7.76 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
7.76 | 12200463 12878042 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Trinitrobenzenesulfonic Acid |
3.51 | 18200517 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.12 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.12 | 11836018 18457598 |
MESH:D007410 |
Intestinal Diseases |
|
Trinitrobenzenesulfonic Acid |
4.44 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.27 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
5.69 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.69 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.69 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
11.69 | 17379185 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.69 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.33 | 16973256 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.12 | 17596541 16294345 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.56 | 16417039 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.03 | 17567588 15342952 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
10.48 | 11408273 17157831 16943688 16239168 16221502 17174718 11903743 17334410 21278145 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
10.48 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
10.48 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.33 | 17481882 17721639 18376398 18279442 15931870 12958196 17557913 12741479 12546737 16027843 12649538 16192424 18472332 15959796 14512876 18429990 17869086 18156304 17922224 12632512 14716496 17976157 16248980 14716833 16136751 18263696 14620537 14724832 15730626 18418968 16015684 16011737 18210741 17525996 12898905 17944888 15338365 12586293 16638106 17900296 15818738 12445421 18317297 17766677 18395914 16097048 12666154 12609069 18472094 18395095 17823541 17631135 12389079 15996030 17805973 15362042 17761835 18187930 18277467 16033810 17698563 18420326 15370692 12667390 17565644 13678700 17714472 18205269 15673190 17640975 18412020 18339082 15925388 20821823 18006644 15876570 17708605 18481824 12445418 15123356 12632514 15057751 14748882 18705752 18251166 11481614 16116963 18166357 18054572 10355542 15650968 15052691 15893842 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.33 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.33 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
3.95 | 15830285 17285989 15720792 16964402 16246199 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
3.95 | 19363144 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.99 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.54 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
20.91 | 9163691 15890375 2125692 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
20.91 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
20.91 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
20.91 | 19073162 19812893 8742319 15975961 21047994 19482888 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
20.91 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
20.91 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
20.91 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
17.53 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
17.53 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
17.53 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
17.53 | 6150874 1399818 18308698 17172636 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
17.53 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.06 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.09 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
12.63 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
12.63 | 18569708 20135361 18816296 20869020 20064080 17053015 20464547 6695378 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
12.63 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
12.63 | 16019985 17703301 16271038 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
12.63 | 11893704 16337739 6695378 21163286 17909032 15390079 20512841 16271038 10545420 9230183 20970405 1399818 7750092 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
12.63 | 15276417 16712894 19931552 17306315 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
12.63 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
12.63 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
3.82 | 15790496 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
4.88 | 15375218 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.98 | 11161223 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.59 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
9.54 | 19196722 19196723 15591091 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
9.54 | 18041768 10767621 10838139 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.54 | 14580682 19196723 11731420 16827153 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.38 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.22 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.22 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.01 | 15990972 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.81 | 17943659 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.62 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.07 | 18765137 18803445 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.38 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.06 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.32 | 16497877 |
MESH:D020391 |
Muscular Dystrophy, Facioscapulohumeral |
marker/mechanism |
|
| 12868502 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.87 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.06 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.88 | 12213967 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.30 | 17484760 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.38 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.48 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.46 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
4.75 | 11141357 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.75 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
8.81 | 16707424 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.81 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
10.36 | 19196722 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
10.36 | 19189210 19196722 19200415 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.27 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.14 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
9.03 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.03 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.97 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
6.97 | 16359493 8888407 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.24 | 16003739 17160924 16651423 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.25 | 18457598 17217161 16723640 21332399 20518802 19632207 11836018 18674790 20132043 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.81 | 17160924 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.19 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.29 | 17882678 19059307 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.07 | 17823083 15758505 15579764 17893378 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.82 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
4.99 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.99 | 15276417 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.43 | 16965848 |
MESH:D010195 |
Pancreatitis |
|
Trinitrobenzenesulfonic Acid |
4.04 | 17698068 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.53 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.08 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.39 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
8.49 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
8.49 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
21.82 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
21.82 | 11222880 11896295 11118676 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
21.82 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
21.82 | 18220299 19015723 18042343 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.76 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.05 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.87 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.87 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
1.87 | 15731164 16536755 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.87 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.87 | 15067354 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.76 | 18629315 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.14 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
11.61 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
11.61 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.17 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.61 | 10548101 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.38 | 15770314 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.67 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.01 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.05 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
5.62 | 16876388 11442880 4039156 3137016 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
5.62 | 16876388 14763951 11738929 3137016 1511512 11044598 17978042 15475178 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.65 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
8.93 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
8.93 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.93 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.98 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.98 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.87 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.11 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.11 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.37 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.55 | 20155912 2093021 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.69 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.81 | 16684133 16045194 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.46 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.01 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
4.99 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.73 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
2.93 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.04 | 19048282 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.06 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.35 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.39 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
11.39 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
11.39 | 17306315 16452187 16712894 11723127 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
11.39 | 16712894 17572228 8653321 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.47 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.62 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.84 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.13 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.81 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.25 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.42 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.04 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.38 | 14671159 15869587 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.38 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.08 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.59 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.27 | 17120751 |